Characterization of a unique technique for culturing primary adult human epithelial progenitor/"stem cells".

PubWeight™: 0.81‹?›

🔗 View Article (PMC 3441704)

Published in BMC Dermatol on June 24, 2012

Authors

Cynthia Luz Marcelo1, Antonio Peramo, Amala Ambati, Stephen E Feinberg

Author Affiliations

1: Department of Surgery, Section of Plastic and Reconstructive Surgery, University of Michigan, MSRBII, A560 1150 W, Medical Center Dr,, Ann Arbor, MI, 48109, USA. cmarcelo@med.umich.edu

Articles cited by this

mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol (2010) 21.16

Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94

Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol (2008) 10.63

p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A (2001) 6.07

Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proc Natl Acad Sci U S A (2011) 5.53

Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J (2008) 2.82

Progress in understanding reprogramming to the induced pluripotent state. Nat Rev Genet (2011) 2.81

Cell size as a determinant of the clone-forming ability of human keratinocytes. Proc Natl Acad Sci U S A (1985) 2.34

Identification of a major keratinocyte cell envelope protein, loricrin. Cell (1990) 2.25

Involucrin synthesis is correlated with cell size in human epidermal cultures. J Cell Biol (1981) 2.14

Turning straw into gold: directing cell fate for regenerative medicine. Nat Rev Genet (2011) 1.73

Keratins and skin disorders. J Pathol (2004) 1.48

Effect of growth environment on spatial expression of involucrin by human epidermal keratinocytes. Arch Dermatol Res (1987) 1.36

Genetic engineering of mesenchymal stem cells and its application in human disease therapy. Hum Gene Ther (2010) 1.19

Location and phenotype of human adult keratinocyte stem cells of the skin. Differentiation (2004) 1.16

Development and characterization of a tissue-engineered human oral mucosa equivalent produced in a serum-free culture system. J Dent Res (2000) 1.11

Cardiogenesis from human embryonic stem cells. Circ J (2010) 1.00

Alzheimer's disease and neural transplantation as prospective cell therapy. Curr Alzheimer Res (2005) 1.00

Interleukin-8 is essential for normal urothelial cell survival. Am J Physiol Renal Physiol (2009) 0.99

Skin keratinocytes pre-treated with embryonic stem cell-conditioned medium or BMP4 can be directed to an alternative cell lineage. Cell Prolif (2007) 0.98

Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67. J Invest Dermatol (1994) 0.85

Challenges of primate embryonic stem cell research. Cloning Stem Cells (2005) 0.84

Pharmacological retention of oral mucosa progenitor/stem cells. J Dent Res (2009) 0.84

Small proline-rich protein 1 is the major component of the cell envelope of normal human oral keratinocytes. FEBS Lett (2000) 0.84

Efficient retroviral gene transfer to epidermal stem cells. Methods Mol Biol (2008) 0.79

In vitro model of essential fatty acid deficiency. J Invest Dermatol (1992) 0.79

Normalization of essential-fatty-acid-deficient keratinocytes requires palmitic acid. J Invest Dermatol (1994) 0.78

Articles by these authors

Bone tissue engineering using polycaprolactone scaffolds fabricated via selective laser sintering. Biomaterials (2005) 2.66

Branchial cleft or cervical lymphoepithelial cysts: etiology and management. J Am Dent Assoc (2003) 1.36

Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures. Biomaterials (2002) 1.26

Development of a tissue-engineered human oral mucosa: from the bench to the bed side. Cells Tissues Organs (2004) 1.20

Inactivation or loss of TTP promotes invasion in head and neck cancer via transcript stabilization and secretion of MMP9, MMP2, and IL-6. Clin Cancer Res (2013) 0.98

2007 research summit: at the forefront of innovation. J Oral Maxillofac Surg (2008) 0.96

Evaluation of transplanted tissue-engineered oral mucosa equivalents in severe combined immunodeficient mice. Tissue Eng (2003) 0.94

Osteochondromas of the mandible: case reports and rationale for treatment. J Oral Maxillofac Surg (2005) 0.89

Acoustic microscopy analyses to determine good vs. failed tissue engineered oral mucosa under normal or thermally stressed culture conditions. Ann Biomed Eng (2010) 0.87

Ex vivo produced human conjunctiva and oral mucosa equivalents grown in a serum-free culture system. J Oral Maxillofac Surg (2004) 0.86

Comparison of scanning acoustic microscopy and histology images in characterizing surface irregularities among engineered human oral mucosal tissues. Ultrasound Med Biol (2011) 0.85

Tissue-engineered constructs of human oral mucosa examined by Raman spectroscopy. Tissue Eng Part C Methods (2012) 0.84

In vivo electrical conductivity across critical nerve gaps using poly(3,4-ethylenedioxythiophene)-coated neural interfaces. Plast Reconstr Surg (2010) 0.84

Constitutive release of cytokines by human oral keratinocytes in an organotypic culture. J Oral Maxillofac Surg (2009) 0.83

The temporalis muscle flap in contemporary oral and maxillofacial surgery. Oral Maxillofac Surg Clin North Am (2003) 0.82

Skin and oral mucosal substitutes. Oral Maxillofac Surg Clin North Am (2002) 0.81

Characterizing morphology and nonlinear elastic properties of normal and thermally stressed engineered oral mucosal tissues using scanning acoustic microscopy. Tissue Eng Part C Methods (2012) 0.81

Non-linear stress-strain measurements of ex vivo produced oral mucosal equivalent (EVPOME) compared to normal oral mucosal and skin tissue. Conf Proc IEEE Eng Med Biol Soc (2011) 0.81

Human oral mucosa tissue-engineered constructs monitored by Raman fiber-optic probe. Tissue Eng Part C Methods (2015) 0.80

Tissue engineering of lips and muco-cutaneous junctions: in vitro development of tissue engineered constructs of oral mucosa and skin for lip reconstruction. Tissue Eng Part C Methods (2011) 0.80

Intraoral grafting of tissue-engineered human oral mucosa. Int J Oral Maxillofac Implants (2013) 0.79

Enrichment of oral mucosa and skin keratinocyte progenitor/stem cells. Methods Mol Biol (2013) 0.79

Development and characterization of a canine oral mucosa equivalent in a serum-free environment. J Biomed Mater Res A (2004) 0.78

Isolation of small-sized human epidermal progenitor/stem cells by Gravity Assisted Cell Sorting (GACS). J Dermatol Sci (2009) 0.76

Characterization of cultured epithelial cells using a novel technique not requiring enzymatic digestion for subculturing. Cell Tissue Bank (2012) 0.76

Tissue matrices for soft tissue and mucosal augmentation and replacement. Facial Plast Surg (2002) 0.76

Hypoxia induces an undifferentiated phenotype of oral keratinocytes in vitro. Cells Tissues Organs (2015) 0.75

Regeneration of the mandibular condyle in minipigs. J Oral Maxillofac Surg (2006) 0.75

Protocol for serial cultivation of epithelial cells without enzymes or chemical compounds. Methods Mol Biol (2014) 0.75

Implementing tissue engineering and regenerative medicine solutions in medical implants. Br Med Bull (2013) 0.75

Subcutaneous tissue response to titanium, poly(ε-caprolactone), and carbonate-substituted hydroxyapatite-coated poly(ε-caprolactone) plates: a rabbit study. J Biomed Mater Res A (2013) 0.75

Proceedings of the American Association of Oral and Maxillofacial Surgeons 2009 Research Summit. J Oral Maxillofac Surg (2010) 0.75

Segmental mandibular bone reconstruction with a carbonate-substituted hydroxyapatite-coated modular endoprosthetic poly(ɛ-caprolactone) scaffold in Macaca fascicularis. J Biomed Mater Res B Appl Biomater (2013) 0.75

Synthesis and characterization of cytocompatible sulfonated polyanilines. Macromol Rapid Commun (2011) 0.75